During the past decade, Cardiovascular Associates of East Texas conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 10 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 9 clinical trials were completed. i.e. 450% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cardiovascular Associates of East Texas" #1 sponsor was "Abbott Medical Devices" with 4 trials, followed by "Boehringer Ingelheim" with 2 trials sponsored, "Horizons International Peripheral Group" with 2 trials sponsored, "Avinger, Inc." with 1 trials sponsored and "Cardio Flow, Inc." with 1 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cardiovascular Associates of East Texas" #1 collaborator was "Advanced Catheter Therapies, Inc." with 2 trials as a collaborator, "ClinLogix. LLC" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Libra Medical" with 1 trials as a collaborator and "Massachusetts General Hospital" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Cardiovascular Associates of East Texas" are "Peripheral Arterial Disease" (7 trials), "Angina Pectoris" (2 trials), "Bradycardia" (2 trials), "Cardiovascular Disease" (2 trials) and "Peripheral Vascular Disease" (2 trials). Many other conditions were trialed in "Cardiovascular Associates of East Texas" in a lesser frequency.

Most popular intervention types in "Cardiovascular Associates of East Texas" are "Device" (10 trials), "Other" (4 trials), "Drug" (2 trials) and "Genetic" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Paclitaxel administration using the OPC" (2 trials), "Ad5FGF-4" (1 trials), "Atherectomy Catheter" (1 trials) and "BioMimics 3D Vascular Stent System" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cardiovascular Associates of East Texas" are 20 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Cardiovascular Associates of East Texas". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Cardiovascular Associates of East Texas, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Cardiovascular Associates of East Texas, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 10 trials that are defined as “Not Applicable".